Human antibodies specific for interleukin 15 (IL-15)

Details for Australian Patent Application No. 2002332628 (hide)

Owner Genmab A/S

Inventors Van Dijk, Marcus Antonius; Gerritsen, Arnout F.; Van De Winkel, Jan G. J.; Baadsgaard, Ole; Schuurman, Janine

Agent Watermark

Pub. Number AU-B-2002332628

PCT Number PCT/US02/26769

PCT Pub. Number WO2003/017935

Priority 60/314,731 23.08.01 US

Filing date 23 August 2002

Wipo publication date 10 March 2003

Acceptance publication date 26 July 2007

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/314,731 23.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002332628

26 July 2007 Application Accepted

  Published as AU-B-2002332628

22 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002332629-CONTENT ADDRESSABLE MEMORY WITH PROGRAMMABLE WORD WIDTH AND PROGRAMMABLE PRIORITY

2002332627-BURNERS AND COMBUSTION APPARATUS FOR CARBON NANOMATERIAL PRODUCTION